The new unit centralizes care for patients in research studies and expands capacity to allow more people to participate in early-phase clinical trials at OHSU. Patrick McCormick, M.B.A., vice president of oncology services in the Knight Cancer Institute, speaks with staff members on Aug. 23, 2021. (OHSU/Joe Rojas-Burke)

The 13,000-square-foot early-phase research unit includes 12 treatment spaces, eight chairs, four beds, and procedure and consultation rooms. The units team of physicians, nurses, pharmacists, data coordinators and clinical research coordinators are trained and experienced in caring for people participating in cancer clinical trials. Trisha Silbernagel, RN, BSN, early-phase clinical trial unit manager, checks equipment on Aug. 23, 2021. (OHSU/Joe Rojas-Burke)

(left to right): Nicola Long, Jeffrey Tyner, Ph.D., Kara Johnson, and Cristina Tognon, Ph.D. co-authored new research published in Cancer Cell. Their findings are the latest from the OHSU Knight Cancer Institutes Beat AML platform for analyzing the cancer cell gene expression, drug sensitivities, and medical outcomes of more than 800 people with acute myeloid leukemia. (OHSU/Christine Torres Hicks)

Shannon McWeeney, Ph.D., professor and head of the Division of Bioinformatics and Computational Biology and an OHU Knight Cancer Institute researcher, Sept. 12, 2018. (OHSU/Kristyna Wentz-Graff)

Jeffrey Tyner, Ph.D., professor of cell, developmental and cancer biology in the OHSU School of Medicine. (OHSU/Christine Torres Hicks)

David Dorr, M.D., M.S., left, chief research information officer and professor of medical informatics and clinical epidemiology in the OHSU School of Medicine, Kyle Ellrott, Ph.D., center, assistant professor of biomedical engineering in the OHSU School of Medicine, is part of the Bridge Center, and Shannon McWeeney, Ph.D., right, chief data officer for the OHSU Knight Cancer Institute. (OHSU)

Brielle, a young cancer survivor who received treatment at OHSU, received sodium thiosulfate following several chemotherapy sessions. (Courtesy of Jennifer Boesche)

Luiz Bertassoni, D.D.S., Ph.D., and his cancer research team at the OHSU Knight Cancer Research Building. (OHSU/Christine Torres Hicks)